SPILINGA, MARTINA
SPILINGA, MARTINA
ONCOLOGIA
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro
2020-01-01 Gallo S.; Spilinga M.; Albano R.; Ferrauto G.; Di Gregorio E.; Casanova E.; Balmativola D.; Bonzano A.; Boccaccio C.; Sapino A.; Comoglio P.M.; Crepaldi T.
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing
2021-01-01 Galluzzo A.; Gallo S.; Pardini B.; Birolo G.; Fariselli P.; Boretto P.; Vitacolonna A.; Peraldo-Neia C.; Spilinga M.; Volpe A.; Celentani D.; Pidello S.; Bonzano A.; Matullo G.; Giustetto C.; Bergerone S.; Crepaldi T.
Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody
2020-01-01 Modica C.; Gallo S.; Chiriaco C.; Spilinga M.; Comoglio P.M.; Crepaldi T.; Basilico C.; Vigna E.
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3
2020-01-01 Gallo S.; Spilinga M.; Casanova E.; Bonzano A.; Boccaccio C.; Comoglio P.M.; Crepaldi T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro | 2020 | Gallo S.; Spilinga M.; Albano R.; Ferrauto G.; Di Gregorio E.; Casanova E.; Balmativola D.; Bonzano A.; Boccaccio C.; Sapino A.; Comoglio P.M.; Crepaldi T. | |
| Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing | 2021 | Galluzzo A.; Gallo S.; Pardini B.; Birolo G.; Fariselli P.; Boretto P.; Vitacolonna A.; Peraldo-Neia C.; Spilinga M.; Volpe A.; Celentani D.; Pidello S.; Bonzano A.; Matullo G.; Giustetto C.; Bergerone S.; Crepaldi T. | |
| Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody | 2020 | Modica C.; Gallo S.; Chiriaco C.; Spilinga M.; Comoglio P.M.; Crepaldi T.; Basilico C.; Vigna E. | |
| The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 | 2020 | Gallo S.; Spilinga M.; Casanova E.; Bonzano A.; Boccaccio C.; Comoglio P.M.; Crepaldi T. |